Clinical Trial Update: A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women [Phase 2]

View source ↗

Summary

A Phase 2 long-term safety study evaluating Asoprisnil and estrogen in postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Asoprisnil (asoprisnil)
• Estrogen (Estrogen)

Snippet

Sponsor: Abbott | Conditions: Postmenopause | Phase 2 | Status: COMPLETED